These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 17214072

  • 1. Neuroleptic malignant syndrome: a review and report of six cases.
    Kasantikul D, Kanchanatawan B.
    J Med Assoc Thai; 2006 Dec; 89(12):2155-60. PubMed ID: 17214072
    [Abstract] [Full Text] [Related]

  • 2. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F, Dor E, Benoit M, Dupuis G, Serret S, Myquel M, Seddiki Y.
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [Abstract] [Full Text] [Related]

  • 3. Diagnosis and treatment of neuroleptic malignant syndrome.
    Guerrero RM, Shifrar KA.
    Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
    [Abstract] [Full Text] [Related]

  • 4. [Diazepam-responsive malignant catatonia in a patient with an initial clinical diagnosis of neuroleptic malignant syndrome: a case report].
    Mishima T, Tsuboi Y, Higuchi MA, Tsugawa J, Obata T, Yamada T.
    Brain Nerve; 2011 May; 63(5):503-7. PubMed ID: 21515931
    [Abstract] [Full Text] [Related]

  • 5. Neuroleptic malignant syndrome among acute psychiatric admissions in Barbados.
    Mansoor GA, Corbin DO, Edwards CN, Nicholson GD, Asokan G, Bannister P.
    West Indian Med J; 1992 Mar; 41(1):15-8. PubMed ID: 1566588
    [Abstract] [Full Text] [Related]

  • 6. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
    Borovicka MC, Bond LC, Gaughan KM.
    Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
    [Abstract] [Full Text] [Related]

  • 7. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
    Marelli A, Bodini P, Dizioli P, Chiodelli G, Guarneri M, Boldori L.
    Minerva Med; 1996 Jan; 87(1-2):45-51. PubMed ID: 8610025
    [Abstract] [Full Text] [Related]

  • 8. [Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS].
    Andreassen MD, Pedersen S.
    Ugeskr Laeger; 2000 Mar 06; 162(10):1366-70. PubMed ID: 10745673
    [Abstract] [Full Text] [Related]

  • 9. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S, Kornreich C, Choubani Z, Gourevitch R.
    Encephale; 2008 Dec 06; 34(6):618-24. PubMed ID: 19081460
    [Abstract] [Full Text] [Related]

  • 10. Zuclopenthixol-induced neuroleptic malignant syndrome in an adolescent girl.
    Erermis S, Bildik T, Tamar M, Gockay A, Karasoy H, Ercan ES.
    Clin Toxicol (Phila); 2007 Dec 06; 45(3):277-80. PubMed ID: 17453880
    [Abstract] [Full Text] [Related]

  • 11. Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome.
    Lee JW.
    J Clin Psychopharmacol; 2010 Feb 06; 30(1):3-10. PubMed ID: 20075641
    [Abstract] [Full Text] [Related]

  • 12. Neuroleptic malignant syndrome with delayed onset of fever following risperidone administration.
    Norris B, Angeles V, Eisenstein R, Seale JP.
    Ann Pharmacother; 2006 Dec 06; 40(12):2260-4. PubMed ID: 17119106
    [Abstract] [Full Text] [Related]

  • 13. Neuroleptic malignant syndrome: physiological and laboratory findings in a series of nine cases.
    Harsch HH.
    J Clin Psychiatry; 1987 Aug 06; 48(8):328-33. PubMed ID: 2886491
    [Abstract] [Full Text] [Related]

  • 14. Severe catatonia and neuroleptic malignant syndrome: report of 3 cases.
    Kasantikul D, Kanchananakhin P.
    J Med Assoc Thai; 1999 Sep 06; 82(9):942-6. PubMed ID: 10561954
    [Abstract] [Full Text] [Related]

  • 15. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
    Sokoro AA, Zivot J, Ariano RE.
    Ann Pharmacother; 2011 Sep 06; 45(9):e50. PubMed ID: 21878660
    [Abstract] [Full Text] [Related]

  • 16. Detection and management of the neuroleptic malignant syndrome.
    Bond WS.
    Clin Pharm; 1984 Sep 06; 3(3):302-7. PubMed ID: 6145537
    [Abstract] [Full Text] [Related]

  • 17. Neuroleptic malignant syndrome from central nervous system insult: 4 cases and a novel treatment strategy. Clinical article.
    Wait SD, Ponce FA, Killory BD, Wallace D, Rekate HL.
    J Neurosurg Pediatr; 2009 Sep 06; 4(3):217-21. PubMed ID: 19772404
    [Abstract] [Full Text] [Related]

  • 18. The neuroleptic malignant syndrome.
    Smego RA, Durack DT.
    Arch Intern Med; 1982 Jun 06; 142(6):1183-5. PubMed ID: 6124221
    [Abstract] [Full Text] [Related]

  • 19. Neuroleptic malignant syndrome: further lessons from a case report.
    Casamassima F, Lattanzi L, Perlis RH, Litta A, Fui E, Bonuccelli U, Fricchione G, Cassano GB.
    Psychosomatics; 2010 Jun 06; 51(4):349-54. PubMed ID: 20587766
    [Abstract] [Full Text] [Related]

  • 20. ECT as a treatment alternative for patients with symptoms of neuroleptic malignant syndrome.
    Addonizio G, Susman VL.
    J Clin Psychiatry; 1987 Mar 06; 48(3):102-5. PubMed ID: 2880837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.